Genomma Lab Internacional. de Dividends and Buybacks
Dividend criteria checks 3/6
Genomma Lab Internacional. de is a dividend paying company with a current yield of 3% that is well covered by earnings.
Key information
3.0%
Dividend yield
0.3%
Buyback Yield
| Total Shareholder Yield | 3.3% |
| Future Dividend Yield | 2.8% |
| Dividend Growth | 14.6% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | Mex$0.800 |
| Payout ratio | 12% |
Recent dividend and buyback updates
Recent updates
Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet
Oct 17
Calculating The Intrinsic Value Of Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB)
Sep 11With Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) It Looks Like You'll Get What You Pay For
Jul 12These 4 Measures Indicate That Genomma Lab Internacional. de (BMV:LABB) Is Using Debt Reasonably Well
May 31Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly
Jan 29Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 49% Discount?
Nov 07Is Genomma Lab Internacional. de (BMV:LABB) Using Too Much Debt?
Mar 31Is Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Trading At A 32% Discount?
Feb 24Does Genomma Lab Internacional. de (BMV:LABB) Have A Healthy Balance Sheet?
Dec 07Rainbows and Unicorns: Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Analysts Just Became A Lot More Optimistic
Sep 24Analysts Just Made A Major Revision To Their Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) Revenue Forecasts
Aug 01Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet
Jul 27Here's Why Genomma Lab Internacional. de (BMV:LABB) Can Manage Its Debt Responsibly
Mar 22Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 44%?
Feb 15Genomma Lab Internacional. de (BMV:LABB) Seems To Use Debt Quite Sensibly
Nov 24Here's Why I Think Genomma Lab Internacional. de (BMV:LABB) Is An Interesting Stock
Sep 08Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Intrinsic Value Is Potentially 96% Above Its Share Price
Jun 10Is Genomma Lab Internacional. de (BMV:LABB) A Risky Investment?
May 24Should You Be Adding Genomma Lab Internacional. de (BMV:LABB) To Your Watchlist Today?
May 06Investors Who Bought Genomma Lab Internacional. de (BMV:LABB) Shares Five Years Ago Are Now Up 65%
Mar 13Genomma Lab Internacional. de (BMV:LABB) Has A Pretty Healthy Balance Sheet
Feb 19Do Its Financials Have Any Role To Play In Driving Genomma Lab Internacional, S.A.B. de C.V.'s (BMV:LABB) Stock Up Recently?
Feb 02Are Investors Undervaluing Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB) By 42%?
Jan 15What Is The Ownership Structure Like For Genomma Lab Internacional, S.A.B. de C.V. (BMV:LABB)?
Dec 28Genomma Lab Internacional. de (BMV:LABB) Shareholders Have Enjoyed A 54% Share Price Gain
Dec 10
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, LAB B has been paying a dividend for less than 10 years.
Growing Dividend: LAB B's dividend payments have increased, but the company has only paid a dividend for 3 years.
Dividend Yield vs Market
| Genomma Lab Internacional. de Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (LAB B) | 3.0% |
| Market Bottom 25% (MX) | 2.6% |
| Market Top 25% (MX) | 7.0% |
| Industry Average (Pharmaceuticals) | 2.4% |
| Analyst forecast (LAB B) (up to 3 years) | 2.8% |
Notable Dividend: LAB B's dividend (3%) is higher than the bottom 25% of dividend payers in the MX market (2.58%).
High Dividend: LAB B's dividend (3%) is low compared to the top 25% of dividend payers in the MX market (7.03%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (11.6%), LAB B's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (33.5%), LAB B's dividend payments are well covered by cash flows.